Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma.
Yijun LiuQingluan LiuZhicheng WangMeilin ChenYi ChenXiayu LiDonghai HuangSongqing FanWei XiongGuiyuan LiWenling ZhangPublished in: Journal of clinical laboratory analysis (2020)
The overexpression of cyclin D1 is a good prognostic marker for NPC.